+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Molecular Oncology Diagnostics Market - Global Forecast 2026-2032- Product Image
Molecular Oncology Diagnostics Market - Global Forecast 2026-2032- Product Image
New

Molecular Oncology Diagnostics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 195 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5925194
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The molecular oncology diagnostics market is rapidly evolving, driven by demand for precise genomic insights, technology innovation, and the need for scalable clinical solutions. Stakeholders navigating this space must balance advancements in sequencing and informatics with shifting regulatory and commercial imperatives to deliver impactful patient outcomes.

Molecular Oncology Diagnostics Market Snapshot

The Molecular Oncology Diagnostics Market grew from USD 2.23 billion in 2025 to USD 2.85 billion in 2026. It is expected to continue expanding at a CAGR of 30.13%, reaching USD 14.11 billion by 2032. This growth reflects increasing adoption of genomics-driven cancer diagnostics, surge in companion diagnostics, liquid biopsy advancements, and sustained investment across leading health systems worldwide.

Scope & Segmentation of Molecular Oncology Diagnostics

The report offers a granular analysis to guide strategic market entry, product innovation, and investment, covering:

  • Product Types: Instruments, reagents and kits, software, and diagnostic services shape value delivery from sample to result.
  • Technology Platforms: Fluorescence in situ hybridization, immunohistochemistry, microarray, next generation sequencing (including targeted, whole exome, and whole genome approaches), and real time PCR.
  • Test Types: Liquid biopsy, multi-gene panel testing, single gene assays, and comprehensive genomic profiling adopt unique roles across cancer care pathways.
  • Applications: Companion diagnostics, early detection, prognosis, monitoring, and research use cases drive clinical adoption and regulatory strategy.
  • Cancer Types: Key focus areas include breast, colorectal, lung, leukemia, prostate, and other tumor classes, reflecting varying biomarker-driven testing demands.
  • End Users: Diagnostic laboratories, hospitals and clinics, pharmaceutical/biotech firms, and research institutes reflect diverse operational and procurement requirements.
  • Sample Types: Tissue, plasma, whole blood, saliva, and urine each introduce unique workflows and inform assay sensitivity and adoption.
  • Regional Coverage: Americas, Europe, Asia-Pacific, Middle East, and Africa—each displaying heterogeneous regulatory, clinical, and laboratory maturity.

Key Takeaways for Senior Decision-Makers

  • Vertical integration and end-to-end diagnostic solutions are aligning informatics, instrumentation, and reagents, promoting both collaboration and competitive pressures across the value chain.
  • High-throughput sequencing and liquid biopsy maturation are expanding the breadth of cancer genomic profiling, enabling more personalized therapy guidance and longitudinal disease monitoring.
  • Regulatory adaptation and payer scrutiny are influencing evidence generation, driving industry emphasis on real-world validation and health-economic outcomes for clinical adoption.
  • Commercial models are diversifying, with increased uptake of subscription-based software, reagent-as-a-service, and managed testing agreements that address varied customer profiles and operational needs.
  • Workforce training, data governance, and quality assurance are emerging as critical differentiators as testing expands from centralized reference labs to decentralized hospital settings.

Molecular Oncology Diagnostics Market: Tariff and Trade Impact

Tariff policies, particularly in the United States, are impacting procurement and cost structures along the diagnostics supply chain. Adjustments to tariff regimes or classifications can disrupt vendor relationships and influence manufacturers to localize sourcing or reevaluate contract terms. Procurement cycles and capital equipment purchasing decisions for clinical laboratories may also shift in response to changing landed costs and trade uncertainty. Maintaining supply chain continuity and proactively adapting to policy changes is increasingly important for all stakeholders.

Research Methodology & Data Sources

This report leverages a robust multi-method research approach. Primary inputs include structured interviews with clinical laboratory directors, hospital leadership, regulatory experts, and industry executives. Secondary research synthesizes peer-reviewed literature, clinical guidelines, product documentation, and regulatory filings to contextualize and validate findings. Scenario analysis is incorporated to test supply chain and policy resilience, ensuring actionable and credible outcomes.

Why This Report Matters

  • Enables diagnostic developers and healthcare providers to prioritize investments across rapidly shifting technology, product, and application segments.
  • Delivers region-specific insights for navigating regulatory complexity, capacity disparities, and varying commercialization strategies worldwide.
  • Supports strategic planning and risk management by illuminating the interplay of evidence generation, payer alignment, and supply chain resilience in molecular oncology diagnostics.

Conclusion

The convergence of sequencing technology, informatics, and collaborative business models is transforming molecular oncology diagnostics. Organizations that align regulatory foresight with robust clinical validation and customer-centric service delivery will realize lasting value and sustained clinical impact as the market evolves.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Molecular Oncology Diagnostics Market, by Product Type
8.1. Instruments
8.2. Reagents & Kits
8.3. Software & Services
9. Molecular Oncology Diagnostics Market, by Technology
9.1. Fluorescence In Situ Hybridization
9.2. Immunohistochemistry
9.3. Microarray
9.4. Next Generation Sequencing
9.4.1. Targeted Sequencing
9.4.1.1. Comprehensive Panel
9.4.1.2. Hotspot Panel
9.4.2. Whole Exome Sequencing
9.4.3. Whole Genome Sequencing
9.5. Real Time PCR
10. Molecular Oncology Diagnostics Market, by Cancer Type
10.1. Breast Cancer
10.2. Colorectal Cancer
10.3. Leukemia
10.4. Lung Cancer
10.5. Prostate Cancer
11. Molecular Oncology Diagnostics Market, by Sample Type
11.1. Plasma Based
11.2. Saliva & Urine
11.3. Tissue Based
11.4. Whole Blood
12. Molecular Oncology Diagnostics Market, by Application
12.1. Companion Diagnostics
12.2. Early Detection
12.3. Personalized Medicine
12.4. Prognosis & Monitoring
12.5. Research Use
13. Molecular Oncology Diagnostics Market, by End User
13.1. Diagnostic Laboratories
13.2. Hospitals & Clinics
13.3. Pharmaceutical & Biotech Companies
13.4. Research Institutes
14. Molecular Oncology Diagnostics Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Molecular Oncology Diagnostics Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Molecular Oncology Diagnostics Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Molecular Oncology Diagnostics Market
18. China Molecular Oncology Diagnostics Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. Agilent Technologies, Inc.
19.7. Bayer AG
19.8. Becton, Dickinson and Company
19.9. Bio-Rad Laboratories, Inc.
19.10. Biocartis NV
19.11. Biocept, Inc.
19.12. BIOMÉRIEUX SA
19.13. Danaher Corporation
19.14. DiaSorin Molecular LLC
19.15. Enzo Biochem, Inc.
19.16. Exact Sciences Corporation
19.17. F. Hoffmann-La Roche Ltd
19.18. GenMark Saglik
19.19. Guardant Health, Inc.
19.20. Hologic, Inc.
19.21. Illumina Inc.
19.22. Leica Biosystems Nussloch GmbH
19.23. Myriad Genetics, Inc.
19.24. NeoGenomics Laboratories
19.25. OncoCyte Corporation
19.26. PathAI, Inc.
19.27. Personal Genome Diagnostics Inc.
19.28. QIAGEN N.V.
19.29. Siemens AG
19.30. Sysmex Asia Pacific Pte Ltd.
19.31. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COMPREHENSIVE PANEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COMPREHENSIVE PANEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COMPREHENSIVE PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY HOTSPOT PANEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY HOTSPOT PANEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY HOTSPOT PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY LEUKEMIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY LEUKEMIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PLASMA BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PLASMA BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PLASMA BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SALIVA & URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SALIVA & URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SALIVA & URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TISSUE BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TISSUE BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TISSUE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY EARLY DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY EARLY DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY EARLY DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PROGNOSIS & MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PROGNOSIS & MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PROGNOSIS & MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY RESEARCH USE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY RESEARCH USE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY RESEARCH USE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. EUROPE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. EUROPE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 142. EUROPE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 143. EUROPE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 144. EUROPE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
TABLE 145. EUROPE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 146. EUROPE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 147. EUROPE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. EUROPE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 160. AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 161. AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 162. AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
TABLE 163. AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 164. AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 165. AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 166. AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 177. ASEAN MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. ASEAN MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 179. ASEAN MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 180. ASEAN MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 181. ASEAN MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
TABLE 182. ASEAN MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 183. ASEAN MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 184. ASEAN MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. ASEAN MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. GCC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. GCC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 188. GCC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 189. GCC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 190. GCC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
TABLE 191. GCC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 192. GCC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 193. GCC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. GCC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 204. BRICS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. BRICS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 206. BRICS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 207. BRICS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 208. BRICS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
TABLE 209. BRICS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 210. BRICS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 211. BRICS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 212. BRICS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. G7 MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. G7 MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 215. G7 MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 216. G7 MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 217. G7 MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
TABLE 218. G7 MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 219. G7 MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 220. G7 MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 221. G7 MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 222. NATO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. NATO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 224. NATO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 225. NATO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 226. NATO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
TABLE 227. NATO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 228. NATO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 229. NATO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 230. NATO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 241. CHINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 242. CHINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 243. CHINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 244. CHINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 245. CHINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
TABLE 246. CHINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 247. CHINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 248. CHINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 249. CHINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Molecular Oncology Diagnostics market report include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biocartis NV
  • Biocept, Inc.
  • BIOMÉRIEUX SA
  • Danaher Corporation
  • DiaSorin Molecular LLC
  • Enzo Biochem, Inc.
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd
  • GenMark Saglik
  • Guardant Health, Inc.
  • Hologic, Inc.
  • Illumina Inc.
  • Leica Biosystems Nussloch GmbH
  • Myriad Genetics, Inc.
  • NeoGenomics Laboratories
  • OncoCyte Corporation
  • PathAI, Inc.
  • Personal Genome Diagnostics Inc.
  • QIAGEN N.V.
  • Siemens AG
  • Sysmex Asia Pacific Pte Ltd.
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages195
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.85 Billion
Forecasted Market Value ( USD ) by 2032 $ 14.11 Billion
Compound Annual Growth Rate30.1%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Cancer/Tumor Profiling Market - Global Forecast 2025-2032 - Product Image

Cancer/Tumor Profiling Market - Global Forecast 2025-2032

  • Report
  • 199 Pages
  • Global
From
Breast Cancer Liquid Biopsy Testing Devices Market - Global Forecast 2025-2032 - Product Image

Breast Cancer Liquid Biopsy Testing Devices Market - Global Forecast 2025-2032

  • Report
  • 191 Pages
  • Global
From
Clinical Oncology Next Generation Sequencing - Global Strategic Business Report - Product Image

Clinical Oncology Next Generation Sequencing - Global Strategic Business Report

  • Report
  • 462 Pages
  • Global
From
Genomic Cancer Panel and Profiling Markets by Cancer, by Application, by Tissue and by Gene Type with Screening Potential Market Size. With Executive and Consultant Guides - Product Image

Genomic Cancer Panel and Profiling Markets by Cancer, by Application, by Tissue and by Gene Type with Screening Potential Market Size. With Executive and Consultant Guides

  • Report
  • 593 Pages
  • Global
From
Next Generation Cancer Diagnostics Global Market Report 2025 - Product Image

Next Generation Cancer Diagnostics Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.